胜利资本提升了Natera股份,而Candriam则削减了Neumora治疗学股份。 Victory Capital boosts Natera shares, while Candriam cuts back on Neumora Therapeutics holdings.

胜利资本管理公司在医学研究公司Natera的股份上增加了11%, Victory Capital Management increased its stake in Natera, a medical research company, by 11% last quarter, acquiring 34,658 more shares. 同时,Candriam S. C. A. Meanwhile, Candriam S.C.A. 将Neumora治疗公司的持有量减少了15.6%,出售了105 217股。 reduced its holdings in Neumora Therapeutics by 15.6%, selling off 105,217 shares. 专注于神经治疗的Neumora Therapeutics公司看到几家经纪公司调整了他们的评级和价格目标, Neumora Therapeutics, focusing on neurological treatments, saw several brokerages adjust their ratings and price targets, with an average rating of "Moderate Buy."